Shearman & Sterling advised the underwriters of Cardinal Health, Inc.’s public offering of $450,000,000 2.400% Notes due 2019, $400,000,000 3.500% Notes due 2024, and $350,000,000 4.500% Notes due 2044. Deutsche Bank Securities Inc., Goldman, Sachs & Co., J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC. acted as joint bookrunning managers for the offering.
Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) is a $91 billion health care services company that improves the cost-effectiveness of health care. Cardinal Health is an essential link in the health care supply chain, providing pharmaceuticals and medical products and services to more than 100,000 locations each day and is also the industry-leading direct-to-home medical supplies distributor. The company is a leading manufacturer of medical and surgical products, including gloves, surgical apparel and fluid management products. In addition, the company operates the nation's largest network of radiopharmacies that dispense products to aid in the early diagnosis and treatment of disease. Ranked #22 on the Fortune 500, Cardinal Health employs 34,000 people worldwide.
The Shearman & Sterling team included associates Elise Corey (New York-Capital Markets), Robert Giannattasio (New York-Corporate), Jennifer Morton (New York-Financial Institutions Advisory & Financial Regulatory) and Jenny Ding (New York-Corporate).